Pulmonology Medical News about Pulmonary neuroendocrine tumors

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pulmonary neuroendocrine/carcinoid tumors
Cancer, 07/01/09

Bertino EM et al. - Although conventional cytotoxic therapy has not been reported to demonstrate much promise in this entity over the past 4 decades, newer molecular targeted agents including those that targeted angiogenesis and the mammalian target of rapamycin (mTOR) pathway have shown encouraging results in early phase trials for advanced carcinoid tumors.

<< Previous
Risk Factors Affecting School Readiness in Premature Infants With...

Next >>
Updating the evidence-base for suctioning adult patients: A...

A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
The Journal of Nuclear Medicine, 11/16/09 Relevance Score: 79%

Pulmonary Crystal-Storing Histiocytoma in a Patient Without a Lymphoproliferative Disorder
The American Journal of the Medical Sciences, 11/13/09 Relevance Score: 67%

Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09 Relevance Score: 67%

Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols
American Journal of Roentgenology, 10/08/09 Relevance Score: 66%

Pulmonary Nodulosis and Aseptic Granulomatous Lung Disease Occurring in Patients with Rheumatoid Arthritis Receiving Tumor Necrosis Factor-alpha-Blocking Agent: A Case Series
Journal of Rheumatology, 10/07/09 Relevance Score: 66%